PLKS IN PD
Elucidating the Role of Phosphorylation by Polo-like kinases in Modulating Alpha-Synuclein Aggregation and Toxicity in Parkinson's disease and Related Disorders
| Coordinatore | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Organization address
address: BATIMENT CE 3316 STATION 1 contact info |
| Nazionalità Coordinatore | Switzerland [CH] |
| Totale costo | 180˙234 € |
| EC contributo | 180˙234 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-IEF-2008 |
| Funding Scheme | MC-IEF |
| Anno di inizio | 2009 |
| Periodo (anno-mese-giorno) | 2009-05-01 - 2011-04-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Organization address
address: BATIMENT CE 3316 STATION 1 contact info |
CH (LAUSANNE) | coordinator | 180˙234.44 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Increasing evidence suggest that alpha-synuclein (a-syn) phosphorylation plays an important role in the regulation of a-syn aggregation, Lewy Bodies (LBs) formation and neurotoxicity in Parkinson’s disease (PD) and related synucleopathies. However, the exact kinase(s) responsible for phosphorylating a-syn and the relationships between phosphorylation, a-syn fibrillogenesis, LB formation and cell death have not been fully elucidated. Preliminary data in our Laboratory have pointed out a Polo-Like Kinase family (Plks) as an interesting candidate for a-syn phosphorylation and modulating protein aggregation. To determine the relationship between the phosphorylation of a-syn by Plk family, protein aggregation and neurodegeneration, we plan to use an integrative approach combining in vitro and in vivo approaches. In the in vitro part, we seek to elucidate the role of phosphorylation by Plks in modulating a-syn aggregation in vitro and in primary cell culture. In the in vivo part, we plan to study the possible co-localization of Plks and phosphorylated and unphosphorylated a-syn in LBs inclusions in the brain of parkinsonians patients and animal models of PD. We also seek to evaluate the biochemical and functional consequences of co-delivering Plks and various modified forms of a-syn directly to the rodent brain. This proposal will give us the opportunity to better understand functional consequences of a-syn phosphorylation and mechanisms by which it contributes to neurotoxicity. That will allow us to identify new therapeutic targets of synucleopathies treatment.'